Cotización Bmo Growth Etf Portfolio... - FDRPX | ADVFN

US Dollar vs MXN

Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

Regístrate

Inicio
Invertir
ETFs
Estados Unidos
NASDAQ
Bmo Growth Etf Portfolio Series T6 Dsc (FDRPX) Cotización

Bmo Growth Etf Portfolio Series T6 Dsc (FDRPX)

0.00

0.00

(0.00%)

Al cierre: 26 Diciembre 3:00PM

Delayed by 15 minutes

0.00

0.00

( 0.00% )

Fuera de horario: -

Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Último Precio

-

Postura de Compra

-

Postura de Venta

-

Volume Operado de la Acción

-

0.00 Rango del Día 0.00

0.00 Rango de 52 semanas 0.00

Precio Anterior

-

Precio de Apertura

-

Hora

Última hora de negociación

-

Volumen promedio (3 m)

-

Volumen financiero

-

Precio Promedio Ponderado

-

No news to show yet.

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	FU
4	0	0	0	0	0	0	0	FU
12	0	0	0	0	0	0	0	FU
26	0	0	0	0	0	0	0	FU
52	0	0	0	0	0	0	0	FU
156	0	0	0	0	0	0	0	FU
260	0	0	0	0	0	0	0	FU

FDRPX - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Bmo Growth Etf Portfolio...?

El precio actual de las acciones de Bmo Growth Etf Portfolio... es US$ 0.00

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Bmo Growth Etf Portfolio...?

Bmo Growth Etf Portfolio... ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
INTZIntrusion Inc	US$ 0.89 (97.78%)	2.19M
EVAXEvaxion Biotech AS	US$ 1.61 (90.31%)	6.84M
LIDRAEye Inc	US$ 1.90 (48.44%)	1.87M
JSPRWJasper Therapeutics Inc	US$ 0.25 (47.06%)	343
CRKNCrown Electrokinetics Corporation	US$ 0.1834 (39.26%)	28.82M
VIRXViracta Therapeutics Inc	US$ 0.1949 (-17.76%)	344.64k
XELBXcel Brands Inc	US$ 0.4401 (-15.19%)	35.45k
LGCBLinkage Global Inc	US$ 0.39 (-14.66%)	33.92k
MITAColiseum Acquisition Corporation	US$ 10.00 (-13.12%)	11.02k
LVROLavoro Ltd	US$ 4.50 (-12.62%)	16.05k
CRKNCrown Electrokinetics Corporation	US$ 0.1834 (39.26%)	28.82M
OMEXOdyssey Marine Exploration Inc	US$ 0.6015 (25.18%)	9.45M
EVAXEvaxion Biotech AS	US$ 1.61 (90.31%)	6.84M
KITTNauticus Robotics Inc	US$ 2.3791 (33.66%)	5.1M
XTIAXTI Aerospace Inc	US$ 0.0401 (0.25%)	4.77M

LowFloatLopes

LowFloatLopes 2 minutos hace

She's still going!!!

funnytimes2

funnytimes2 2 minutos hace

The day before yesterday, I didn't hear you about the last 101 shares, why?

tw0122

tw0122 2 minutos hace

$1.88 Finally the in and out free share accumulation paying off

sctts

sctts 3 minutos hace

Still nothing there

floblu14

floblu14 3 minutos hace

....they actually may have a case against their patent attorneys

I totally agree - wrote this yesterday on the ENTA board:

Suggest Foley Hoag LLP | Law Firm & Barbara Fiacco take the appeal pro bono since they did NOT correct the error after receiving multi-millions f

MartinLutherKing

MartinLutherKing 3 minutos hace

Where are you Roaring Kitty???

sam1933

sam1933 3 minutos hace

🚨LARGE ORGANIZATIONS ARE BUYING #HBAR 🚨
💥 $HBAR SECRET REGULATORY CLARITY💥
THIS IS SO BULLISH LONG TERM FOR #Hedera $HBAR HOLDERS
🚨LARGE ORGANIZATIONS ARE BUYING

ATM123

ATM123 4 minutos hace

3 Million plus or around 300 Million plus.....

tw0122

tw0122 4 minutos hace

Nice one not in it

RealDutch

RealDutch 4 minutos hace

Searching for good news

I don't have any :-)

I don't think they have received the $500k yet. I haven't heard anything.

The trip to HK was delayed until the 25th. Then it became the 26th. It will probably be delayed again. I told Likhitha if they don't get

misterfishman

misterfishman 4 minutos hace

Chit your better be a black dude saying that chit here.

bas2020

bas2020 4 minutos hace

Not according to your FUDster pals over there... who seem to be vanishing of late.
Which will happen here, too, upon approval.

SparksEE

SparksEE 5 minutos hace

TrendTrade2016

TrendTrade2016 5 minutos hace

QSI exploding in afterhours

misterfishman

misterfishman 6 minutos hace

We are going into a new year. how about making a new years resolution to be nice to each other or at least try real hard.

lighter than AIR

lighter than AIR 6 minutos hace

That they are…they can even make you talk to monkeys…

johnglenn

johnglenn 6 minutos hace

Down 15%. Horrible day. Throwing myself off a tall building.

ProfitChaser

ProfitChaser 6 minutos hace

Nice info to know. Still holding a nice position there also.

work-n-hard

work-n-hard 7 minutos hace

A little after hours action. How about a PR telling us that the $13M deal closed? 😁

skitahoe

skitahoe 7 minutos hace

I've seen many companies where additional trials were required, it hurts, but if what's requested is deemed reasonable by shareholders the companies have survived, and ultimately thrived. I don't believe it will be needed here, but if I'm wrong, it's already been driven so low that a well designed

Real McCoy

Real McCoy 9 minutos hace

Bioamber has shareholders?

Wasn’t trading stopped years ago??

ProfitChaser

ProfitChaser 9 minutos hace

I dont own this one or know anything about it. Just saw the article and thought I would mention it incase anyone else wants to gamble. I might would grab a little if it was on a different exchange.

https://www.coinspeaker.com/600-in-this-token-could-reach-30000-in-the-next-10-weeks/?

Green doggie

Green doggie 9 minutos hace

What makes you think he’s getting ousted? China did away with two term limits. Xi could be in for life.

dennisdave

dennisdave 10 minutos hace

Clearly the P3 was a mess and they need to run a better trial, but the P3 failure was possibly due to a bad design by NWBO.
thats why the MHRA bought into NWBO pediatric SAP, being the exact same as the DCVAXL trial, because the trial design was a mess?

Bmo Growth Etf Portfolio...

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones